Filter
781
Filtered Results: 781
Text search:
Social
Science
in
Humanitarian
Action
Featured
Recommendations
85
New Publications
200
Language
Document type
No document type
409
Studies & Reports
175
Guidelines
72
Manuals
49
Strategic & Response Plan
37
Training Material
15
Fact sheets
10
Situation Updates
8
Resource Platforms
5
App
1
Countries / Regions
Global
55
Liberia
27
Sierra Leone
25
Syria
22
Congo, Democratic Republic of
19
Ukraine
17
Kenya
15
Myanmar / Burma
15
Nepal
12
Africa
12
Guinea
11
Uganda
11
Latin America and the Carribbean
11
India
10
Malawi
10
Western and Central Europe
9
Nigeria
8
Mozambique
8
South–East Asia Region
8
Asia
7
Venezuela
7
Ethiopia
6
South Sudan
6
Jordan
6
Lebanon
6
Brazil
6
Yemen
6
West and Central Africa
6
Senegal
5
Ghana
5
Haiti
5
Rwanda
5
East and Southern Africa
5
Western Pacific Region
5
Somalia
4
South Africa
4
Bangladesh
4
Angola
4
Lesotho
4
Eastern Europe
4
Burkina Faso
3
Iraq
3
Zambia
3
Turkey
3
Indonesia
3
Central African Republic
3
Colombia
3
Sri Lanka
3
Eastern Europe and Central Asia
3
Cameroon
2
Philippines
2
Afghanistan
2
Germany
2
Thailand
2
Sudan
2
Namibia
2
Peru
2
Eswatini/ Swaziland
2
Botswana
2
Chile
2
Middle East and North Africa
2
Palestine
2
Laos
2
Canada
2
Vietnam
2
Portugal
2
Mali
1
Guinea-Bissau
1
Zimbabwe
1
Egypt
1
Tanzania
1
Cambodia
1
China
1
Argentina
1
Burundi
1
Bolivia
1
Libya
1
Mexico
1
Bhutan
1
Italy
1
Armenia
1
Tajikistan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
188
Key Resources
80
Women & Child Health
55
Public Health
47
Clinical Guidelines
23
Capacity Building
10
Pharmacy & Technologies
2
Protection & Security
1
Toolboxes
COVID-19
120
Mental Health
76
Planetary Health
53
Ebola
47
HIV
47
Conflict
43
Disability
35
Refugee
26
Global Health Education
24
Natural Hazards
22
Rapid Response
19
Health Financing Toolbox
14
Caregiver
12
TB
10
NTDs
9
Polio
7
Specific Hazards
7
Pharmacy
7
Zika
6
Social Ethics
3
NCDs
3
AMR
2
Cholera
1
South Sudan
1
The report will describe how the Ebola Response MPTF, which has attracted contributions from 38 Member States, one business and many individuals, has offered a transparent and strategic tool to support the Ebola response. As of 31 January 2015, the Fund had total pledges amounting to US$142 million,...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos...
Defending Rights
Breaking Barriers
Reaching People with HIV Services
Global Aids Update 2019
A Joint Position Statement of the Indian Society of Critical Care Medicine (ISCCM) and the Indian
Association of Palliative Care (IAPC)
Indian Journal of Critical Care Medicine September 2014 Vol 18 Issue 9
This is a guidance document for countries and implementing partners on the technical requirements for developing digital information systems for issuing standards-based interoperable digital certificates for COVID-19 vaccination status, and considerations for implementation of such systems, for the ...
Esta nota de instrução resume as principais considerações em Saúde Mental e Apoio Psicossocial (SMAPS) referen-tes ao novo surto de coronavírus (COVID-19). Este documento foi atualizado pela última vez em 17 de março de 2020.
Le Burkina Faso est un pays sahélien sans littoral d’une superficie de 274 000 km2 et une
population estimée à 17,4 millions d’habitants en 2013 avec une croissance démographique de
3,1%. C’est l’un des pays les plus pauvres du monde avec un Produit intérieur brut par tête de
684 US...
SBMFC Recommendations for PHC during the Pandemic of COVID-19 (edition 4)
This document answers questions and gives recommendations so that the Brazilian PHC can quickly receive the best possible scientific synthesis on the current situation of the pandemic of COVID-19
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published ... 2020, included a special insert mapping the
challenges posed by the COVID-19 pandemic in relation
to the integrated health, trade and IP policy framework set
out in the study. The Trilateral Study and the special insert
were designed to serve as background reference for policy-
makers in the widest sense – lawmakers, government
officials, delegates to international organizations, non-
governmental organizations (NGOs) and researchers
who seek a comprehensive presentation of the full range
of issues, including institutions and legal concepts with
which they may be unfamiliar. It is also designed to serve
as a factual resource for the three organizations’ technical
cooperation activities.
This update revises the information contained in that
insert in the light of more recent developments as of
30 August 2021. Further updates will be made to reflect
subsequent developments.
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times ... adequate amounts”. However, there is a category of medicines that faces a unique challenge in terms of availability. These are the medicines governed by the international conventions on narcotic and psychotropic substances. “Controlled medicines” is the common definition for pharmaceuticals whose active principles are listed under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol, such as morphine and methadone; the 1971 United Nations Convention on Psychotropic Substances, such as diazepam and buprenorphine; and the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, such as ergometrine and ephedrine. The conventions list substances in “Schedules” according to their different levels of potential for abuse and harm, and the commensurate severity of control measures to be applied by countries.
Access to controlled medicines. 3rd edition
Une note d'orientation interagencesur la collaboration avec les communautés des zones à forte densité pour planifier des approches locales de prévention et de gestion de la COVID-19.
Lignes directrices provisoires, 13 août 2020
L’OMS a établi cette brève note d’information pour répondre au besoin de recommandations sur la prestation sûre de soins à domicile aux patients présumés atteints de l’infection par le nouveau coronavirus (2019-nCoV) présentant des symptô...
